University of Pennsylvania, Department of Neurology
Philadelphia, Pennsylvania, United States
Neurologist in Philadelphia, Pennsylvania
3400 Spruce St, Philadelphia, PA 19104
About University of Pennsylvania, Department of Neurology
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Avanir Pharmaceuticals
2
TauRx Therapeutics Ltd
2
Novartis
1
Revance Therapeutics, Inc.
1
Sunovion
1
Clinical Trials at University of Pennsylvania, Department of Neurology
During the past decade, University of Pennsylvania, Department of Neurology conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
2001-01-01
2002-04-01
Completed
100
Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)
2003-02-01
2007-06-01
Completed
600
Efficacy and Safety of Fingolimod (FTY720) in Patients With Relapsing-remitting Multiple Sclerosis
2006-06-01
2011-08-01
Completed
1,083
Safety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFTD)
2013-05-01
2016-02-01
Completed
220
Open-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)
2014-08-01
2017-05-01
Terminated
913
A Study to Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis
2016-12-31
2020-04-20
Completed
39
Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1)
2018-06-20
2020-06-16
Completed
301
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of Pennsylvania, Department of Neurology" #1 sponsor was "Avanir Pharmaceuticals" with 2 trials, followed by "TauRx Therapeutics Ltd" with 2 trials
sponsored, "Novartis" with 1 trials sponsored, "Revance Therapeutics, Inc." with 1 trials sponsored and "Sunovion"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of Pennsylvania, Department of Neurology"
#1 collaborator was "Syneos Health" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at University of Pennsylvania, Department of Neurology
According to Clinical.Site data, the most researched conditions in "University of Pennsylvania, Department of Neurology" are
"Alzheimer's Disease" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Behavioral Variant Frontotemporal Dementia" (1 trials), "Behavioral Variant Frontotemporal Dementia (bvFTD)" (1 trials) and "Cervical Dystonia" (1 trials). Many other conditions were trialed in "University of Pennsylvania, Department of Neurology" in a lesser frequency.
Clinical Trials Intervention Types at University of Pennsylvania, Department of Neurology
Most popular intervention types in "University of Pennsylvania, Department of Neurology" are "Drug" (6 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "AVP-923" (2 trials), "DaxibotulinumtoxinA for injection" (1 trials), "Fingolimod" (1 trials) and "LMTM" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of Pennsylvania, Department of Neurology
The vast majority of trials in "University of Pennsylvania, Department of Neurology" are
7 trials for "All" genders.
Clinical Trials Status at University of Pennsylvania, Department of Neurology
Currently, there are NaN active trials in "University of Pennsylvania, Department of Neurology".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 6 completed trials in University of Pennsylvania, Department of Neurology,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Pennsylvania, Department of Neurology, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".